The Polish Pharmaceutical Market Increased by 3.6% Between January and April this Year.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c42614) has announced the addition of Polish Pharmaceutical Report to their offering. The Polish Pharmaceutical Sector Report offers an extensive summary of the Polish pharmaceutical market. It includes a complete coverage of the latest developments as well as the latest corporate news accompanied by statistical data. This sector report is ideal to keep you abreast on recent company and industry news. Written by local analysts, it is a unique market and business intelligence analysis, tailored to save time by providing in-depth information, while helping you to make confident and informed business decisions. The report covers the period Feb-May 2006. Topics Covered Overview Pharmaceuticals Manufacturing News Pharmaceuticals Distribution News Appendix Summary According to a market research company IMS Health, the total pharmaceutical market in Poland grew by 3.6% y/y to PLN PLN In currencies, this is the abbreviation for the Polish Zloty. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 5.1bn in net producers prices between January and April this year. The value of the pharmacy market rose by 3.4%, and the segment of prescribed drugs increased by 5.7%. IMS Health analysis indicates that most popular among prescription drugs in that period were the medicines used in the treatment of cardiology diseases, the sales of which grew by PLN 81mn compared to the corresponding period a year earlier, and those used in treatment of nervous system diseases, the sales of which rose by PLN 30mn. The sales of drugs used in the treatment of alimentary system alimentary system n. See digestive system. and respiratory system respiratory system: see respiration. respiratory system Organ system involved in respiration. In humans, the diaphragm and, to a lesser extent, the muscles between the ribs generate a pumping action, moving air in and out of the lungs through a diseases saw a decline in Jan-April 2006, falling by 0.3% y/y and 2.6% y/y respectively. Analysts from IMS Health underline that the situation on the Polish drugs market changes very often due to the emergence of new products and brands. Consumers tend to purchase the newest drugs available, which are usually slightly more expensive. This results in gradual market growth, explains IMS Health. In the twelve months ending March 2006, the pharmaceutical market in Poland in net producers prices reached a value of PLN 14.4bn (EUR EUR In currencies, this is the abbreviation for the Euro. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 3.67bn). Companies Mentioned IMS Health, GlaxoSmithKline (GSK GSK GlaxoSmithKline plc (pharmaceutical company) GSK Glycogen Synthase Kinase GSK Gruppentraining Sozialer Kompetenzen (Germany) GSK Greenland Shark (FAO fish species code) ), Pliva, IVAX IVAX Industrial Vax (Dec Computer) , Sandoz, Sanitas, Bioton,Polski Holding Farmaceutyczny, Polfa Pabianice, Polfa Warszawa, Polfa Tarchomin, Jelfa, Janssen-Cilag, Polpharma, Sanofi-Synthelabo, Sanofi-Aventis, Strides Polska, Roche, ICN ICN International Council of Nurses. Polfa Rzeszow, Adamed, IVAX, PGF PGF Probability Generating Function PGF Perpignan, France - Llabanere (Airport Code) PGF Polypeptide Growth Factor PGF Pen Gun Flare PGF Production Genomic Facility PGF Prince George Freenet PGF Pseudo Green Function , Torfarm, Farmacol, Prosper, CF Cefarm, Cefarm Bialystok, Tamro Group, Orfe, Super-Pharm, Euro Apteka For more information visit http://www.researchandmarkets.com/reports/c42614 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion